Brief: Aptorum Group Limited Receives IND Clearance From U.S. FDA to Initiate Clinical Trials for Treatment of Neuroblastoma

Aptorum

15/09/2021 13:09

Sept 15 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP LIMITED HAS RECEIVED IND CLEARANCE FROM THE
US FDA
TO INITIATE CLINICAL TRIALS FOR REPURPOSED SMALL MOLECULE DRUG
SACT-1 FOR THE TREATMENT OF NEUROBLASTOMA

Source text for Eikon:  ID:nBw5XrH3ma 
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))